{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T18:43:58Z","timestamp":1777661038049,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T00:00:00Z","timestamp":1742601600000},"content-version":"am","delay-in-days":294,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.neuropharm.2024.109927","type":"journal-article","created":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T17:21:52Z","timestamp":1710782512000},"page":"109927","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["\u03b22* nAChR sensitivity modulates acquisition of cocaine self-administration in male rats"],"prefix":"10.1016","volume":"250","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8986-5611","authenticated-orcid":false,"given":"Noah B.","family":"Walker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenton R.","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leanne N.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew E.","family":"Tapp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2035-0481","authenticated-orcid":false,"given":"Anna I.","family":"Neel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5644-4386","authenticated-orcid":false,"given":"Rong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara R.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8141-8577","authenticated-orcid":false,"given":"Ryan M.","family":"Drenan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2024.109927_bib1","series-title":"Key Substance Use and Mental Health Indicators in the United States: Results from the 2017 National Survey on Drug Use and Health","author":"Administration","year":"2018"},{"issue":"4","key":"10.1016\/j.neuropharm.2024.109927_bib2","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0306-4522(03)00378-6","article-title":"Cholinergic interneurons of the nucleus accumbens and dorsal striatum are activated by the self-administration of cocaine","volume":"120","author":"Berlanga","year":"2003","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.neuropharm.2024.109927_bib3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.euroneuro.2004.07.005","article-title":"Effects of nicotinic and NMDA receptor channel blockers on intravenous cocaine and nicotine self-administration in mice","volume":"15","author":"Blokhina","year":"2005","journal-title":"Eur. Neuropsychopharmacol"},{"issue":"45","key":"10.1016\/j.neuropharm.2024.109927_bib4","doi-asserted-by":"crossref","first-page":"44033","DOI":"10.1074\/jbc.M211719200","article-title":"The effects of b3 subunit incorporation on the pharmacology and single channel properties of oocyte-expressed human a3b4 neuronal nicotinic receptors","volume":"278","author":"Boorman","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.109927_bib5","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1124\/mol.106.026682","article-title":"Incorporation of the b3 subunit has a dominant-negative effect on the function of recombinant central-type neuronal nicotinic receptors","volume":"70","author":"Broadbent","year":"2006","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.109927_bib6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0899-3289(93)90056-H","article-title":"Nicotine and caffeine use in cocaine-dependent individuals","volume":"5","author":"Budney","year":"1993","journal-title":"J. Subst. Abuse"},{"issue":"4","key":"10.1016\/j.neuropharm.2024.109927_bib7","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1523\/JNEUROSCI.22-04-01208.2002","article-title":"Distribution and pharmacology of \u03b16-containing nicotinic acetylcholine receptors analyzed with mutant mice","volume":"22","author":"Champtiaux","year":"2002","journal-title":"J. Neurosci."},{"issue":"21","key":"10.1016\/j.neuropharm.2024.109927_bib8","doi-asserted-by":"crossref","first-page":"7820","DOI":"10.1523\/JNEUROSCI.23-21-07820.2003","article-title":"Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice","volume":"23","author":"Champtiaux","year":"2003","journal-title":"J. Neurosci."},{"issue":"22","key":"10.1016\/j.neuropharm.2024.109927_bib9","doi-asserted-by":"crossref","first-page":"6004","DOI":"10.1523\/JNEUROSCI.4494-05.2006","article-title":"Activation of muscarinic and nicotinic acetylcholine receptors in the nucleus accumbens core is necessary for the acquisition of drug reinforcement","volume":"26","author":"Crespo","year":"2006","journal-title":"J. Neurosci."},{"issue":"35","key":"10.1016\/j.neuropharm.2024.109927_bib10","doi-asserted-by":"crossref","first-page":"11045","DOI":"10.1523\/JNEUROSCI.23-35-11045.2003","article-title":"The \u03b23 nicotinic receptor subunit: a component of \u03b1-Conotoxin MII-binding nicotinic acetylcholine receptors that modulate dopamine release and related behaviors","volume":"23","author":"Cui","year":"2003","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109927_bib11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neuron.2008.09.009","article-title":"In vivo activation of midbrain dopamine neurons via sensitized, high-affinity \u03b16* nicotinic acetylcholine receptors","volume":"60","author":"Drenan","year":"2008","journal-title":"Neuron"},{"issue":"29","key":"10.1016\/j.neuropharm.2024.109927_bib12","doi-asserted-by":"crossref","first-page":"9877","DOI":"10.1523\/JNEUROSCI.2056-10.2010","article-title":"Cholinergic modulation of locomotion and striatal dopamine release is mediated by \u03b16\u03b14* nicotinic acetylcholine receptors","volume":"30","author":"Drenan","year":"2010","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.109927_bib13","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1124\/pr.111.004671","article-title":"Insights into the neurobiology of the nicotinic cholinergic system and nicotine addiction from mice expressing nicotinic receptors harboring gain-of-function mutations","volume":"64","author":"Drenan","year":"2012","journal-title":"Pharmacol. Rev."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.109927_bib14","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1097\/00001756-199906030-00002","article-title":"High affinity binding of [3H]epibatidine to rat brain membranes","volume":"10","author":"Gnadisch","year":"1999","journal-title":"Neuroreport"},{"issue":"4","key":"10.1016\/j.neuropharm.2024.109927_bib15","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/sj.bjp.0704313","article-title":"Formation of functional a3b4a5 human neuronal nicotinic receptors in Xenopus oocytes: a reporter mutation approach","volume":"134","author":"Groot-Kormelink","year":"2001","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109927_bib16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00213-007-0822-z","article-title":"The nicotinic acetylcholine receptor antagonist mecamylamine prevents escalation of cocaine self-administration in rats with extended daily access","volume":"194","author":"Hansen","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"issue":"9","key":"10.1016\/j.neuropharm.2024.109927_bib17","first-page":"1","article-title":"Drugs most frequently involved in drug overdose deaths: United States, 2011-2016","volume":"67","author":"Hedegaard","year":"2018","journal-title":"Natl. Vital Stat. Rep."},{"issue":"2\u20133","key":"10.1016\/j.neuropharm.2024.109927_bib18","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0014-2999(93)90869-J","article-title":"Effects of cocaine and amphetamine on acetylcholine release in the hippocampus and caudate nucleus","volume":"238","author":"Imperato","year":"1993","journal-title":"Eur. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.neuropharm.2024.109927_bib19","doi-asserted-by":"crossref","first-page":"eaax1532","DOI":"10.1126\/sciadv.aax1532","article-title":"The treatment of cocaine use disorder","volume":"5","author":"Kampman","year":"2019","journal-title":"Sci. Adv."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.109927_bib20","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0031-9384(00)00382-6","article-title":"The nicotinic antagonist mecamylamine preferentially inhibits cocaine vs. food self-administration in rats","volume":"71","author":"Levin","year":"2000","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2024.109927_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2018.12.010","article-title":"alpha4beta2 Nicotinic receptor desensitizing compounds can decrease self-administration of cocaine and methamphetamine in rats","volume":"845","author":"Levin","year":"2019","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.109927_bib22","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00213-011-2438-6","article-title":"Acquisition of cocaine self-administration in male Sprague-Dawley rats: effects of cocaine dose but not initial locomotor response to cocaine","volume":"219","author":"Mandt","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109927_bib23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s002130050918","article-title":"Self-administration of cocaine increases the release of acetylcholine to a greater extent than response-independent cocaine in the nucleus accumbens of rats","volume":"143","author":"Mark","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109927_bib24","first-page":"377","article-title":"Differential agonist inhibition identifies multiple epibatidine binding sites in mouse brain","volume":"285","author":"Marks","year":"1998","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"7","key":"10.1016\/j.neuropharm.2024.109927_bib25","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1046\/j.1460-9568.2003.02564.x","article-title":"Effects of nicotine in the dopaminergic system of mice lacking the \u03b14 subunit of neuronal nicotinic acetylcholine receptors","volume":"17","author":"Marubio","year":"2003","journal-title":"Eur. J. Neurosci."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.109927_bib26","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/npp.2013.325","article-title":"Effects of chronic varenicline treatment on nicotine, cocaine, and concurrent nicotine+cocaine self-administration","volume":"39","author":"Mello","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"31","key":"10.1016\/j.neuropharm.2024.109927_bib27","doi-asserted-by":"crossref","first-page":"6900","DOI":"10.1523\/JNEUROSCI.0023-18.2018","article-title":"Chrna5-expressing neurons in the interpeduncular nucleus mediate aversion primed by prior stimulation or nicotine exposure","volume":"38","author":"Morton","year":"2018","journal-title":"J. Neurosci."},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2024.109927_bib28","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.drugalcdep.2011.08.025","article-title":"Results of an initial clinical trial of varenicline for the treatment of cocaine dependence","volume":"121","author":"Plebani","year":"2012","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.109927_bib29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0376-8716(97)00144-0","article-title":"An acute dose of nicotine enhances cue-induced cocaine craving","volume":"49","author":"Reid","year":"1998","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.109927_bib30","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0893-133X(98)00076-1","article-title":"A nicotine antagonist, mecamylamine, reduces cue-induced cocaine craving in cocaine-dependent subjects","volume":"20","author":"Reid","year":"1999","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109927_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-0270(95)00153-0","article-title":"Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy","volume":"66","author":"Richardson","year":"1996","journal-title":"J. Neurosci. Methods"},{"issue":"6","key":"10.1016\/j.neuropharm.2024.109927_bib32","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1085\/jgp.201812201","article-title":"Determining the pharmacokinetics of nicotinic drugs in the endoplasmic reticulum using biosensors","volume":"151","author":"Shivange","year":"2019","journal-title":"J. Gen. Physiol."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.109927_bib33","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/cne.24381","article-title":"Brain maps 4.0-Structure of the rat brain: an open access atlas with global nervous system nomenclature ontology and flatmaps","volume":"526","author":"Swanson","year":"2018","journal-title":"J. Comp. Neurol."},{"issue":"5698","key":"10.1016\/j.neuropharm.2024.109927_bib34","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1099420","article-title":"Nicotine activation of \u03b14* receptors: sufficient for reward, tolerance, and sensitization","volume":"306","author":"Tapper","year":"2004","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109927_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-24173-x","article-title":"The progressive ratio and fixed ratio 1 schedules of cocaine self-administration in rats convey the same information","volume":"12","author":"Tsibulsky","year":"2022","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.109927_bib36","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0449-22.2023","article-title":"beta2 nAChR activation on VTA DA neurons is sufficient for nicotine reinforcement in rats","volume":"10","author":"Walker","year":"2023","journal-title":"eNeuro"},{"issue":"4","key":"10.1016\/j.neuropharm.2024.109927_bib37","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/sj.bjp.0703616","article-title":"Identification of a novel nicotinic binding site in mouse brain using [125I]-epibatidine","volume":"131","author":"Whiteaker","year":"2000","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.109927_bib38","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1016\/j.celrep.2018.04.062","article-title":"Nicotinic cholinergic receptors in VTA glutamate neurons modulate excitatory transmission","volume":"23","author":"Yan","year":"2018","journal-title":"Cell Rep."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.109927_bib39","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0298-19.2019","article-title":"Differential nicotinic modulation of glutamatergic and GABAergic VTA microcircuits","volume":"6","author":"Yan","year":"2019","journal-title":"eNeuro"},{"issue":"36","key":"10.1016\/j.neuropharm.2024.109927_bib40","doi-asserted-by":"crossref","first-page":"9021","DOI":"10.1523\/JNEUROSCI.0694-08.2008","article-title":"Acetylcholine release in the mesocorticolimbic dopamine system during cocaine seeking: conditioned and unconditioned contributions to reward and motivation","volume":"28","author":"You","year":"2008","journal-title":"J. Neurosci."},{"issue":"12","key":"10.1016\/j.neuropharm.2024.109927_bib41","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/nn769","article-title":"Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum","volume":"4","author":"Zhou","year":"2001","journal-title":"Nat. Neurosci."},{"issue":"13","key":"10.1016\/j.neuropharm.2024.109927_bib42","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1038\/npp.2011.165","article-title":"Brain-cocaine concentrations determine the dose self-administered by rats on a novel behaviorally dependent dosing schedule","volume":"36","author":"Zimmer","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"10.1016\/j.neuropharm.2024.109927_bib43","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.1523\/JNEUROSCI.18-12-04461.1998","article-title":"Identification of four classes of brain nicotinic receptors using beta2 mutant mice","volume":"18","author":"Zoli","year":"1998","journal-title":"J. Neurosci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824000960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824000960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T17:52:27Z","timestamp":1712080347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390824000960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":43,"alternative-id":["S0028390824000960"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.109927","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b22* nAChR sensitivity modulates acquisition of cocaine self-administration in male rats","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.109927","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109927"}}